These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1841042)

  • 1. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Hamilton-Miller JM; Brumfitt W
    Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of cefixime: correlation index between MIC and disc diffusion test.
    Focà A; Liberto MC; Berlinghieri MC; Matera G; Puccio R; Carbone M; Fera MT
    Drugs Exp Clin Res; 1990; 16(4):175-9. PubMed ID: 2076653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
    Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
    Bauernfeind A
    Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefdinir: in vitro activity study and effect of human serum.
    García-Rodríguez JA; Trujillano-Martín I; García-Sánchez JE
    Drugs Exp Clin Res; 1993; 19(2):51-8. PubMed ID: 8223142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
    Debbia EA; Marchese A; Pesce A; Saverino D; Schito GC
    J Chemother; 1992 Jun; 4(3):131-44. PubMed ID: 1517806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefixime versus cefotaxime against gram-negative bacteria causing urinary tract infections.
    Carcía-Rodriguez JA; García-Sanchez JE; García-Garcia MI; García-Sanchez E; Munõz-Bellido JL; Trujillano I
    J Chemother; 1989 Jul; 1(4 Suppl):112-3. PubMed ID: 16312329
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro studies with Bay V 3522, a new oral cephalosporin.
    Thomson KS; Sanders CC; Sanders WE
    Drugs Exp Clin Res; 1991; 17(3):165-73. PubMed ID: 1914843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
    Bianchi P; Frongillo RF
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):488-95. PubMed ID: 6255966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefixime. Microbiologic, kinetic and clinical profile].
    Di Nola F; Arione R; Bramato C
    Minerva Med; 1991 Oct; 82(10):633-56. PubMed ID: 1745375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.
    Barry AL; Jones RN
    Pediatr Infect Dis J; 1987 Oct; 6(10):954-7. PubMed ID: 3696835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
    Neu HC
    Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
    Knothe H; Shah PM; Eckardt O
    Infection; 1991; 19(5):370-6. PubMed ID: 1800379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
    Williams JD; Powell M; Fah YS; Seymour A; Yuan M
    Eur J Clin Microbiol Infect Dis; 1992 Aug; 11(8):748-51. PubMed ID: 1425737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
    Jones RN
    Diagn Microbiol Infect Dis; 1991; 14(1):37-43. PubMed ID: 2013209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
    Mulligan ME
    Infect Control; 1987 Jun; 8(6):241-4. PubMed ID: 3498702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D; Robbins MJ; Ghosh G; Bhogal H; Mehta MD; Leakey A; Clark S; Dencer CA; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1994; 20(4):127-47. PubMed ID: 7813385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and cross resistance studies with cefpodoxime.
    Grimm H
    Zentralbl Bakteriol; 1991 Dec; 276(1):54-62. PubMed ID: 1789901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.